Rady Pediatric Genomics & Systems Medicine Institute
11
5
6
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
ASD Wearables Feasibility Study
Role: lead
Newborn Genomic Sequencing Pilot Study
Role: lead
Immunogenomic Analyses of Pediatric Catatonia
Role: lead
Multiomic Diagnostics in Youth With Psychosis
Role: lead
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
Role: collaborator
Mental Health Crises in Youth With IDDs
Role: lead
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
Role: lead
Perinatal Precision Medicine
Role: lead
Rady Children's Institute Genomic Biorepository
Role: lead
Rapid Whole Genome Sequencing Study
Role: lead
NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants
Role: collaborator
All 11 trials loaded